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1. Introduction 
Although several in vivo [l-3] and whole-cell 
[4-121 studies have demonstrated lung tissue can 
incorporate glycerol into the glycerol backbone of 
lipids, the presence of glycerol kinase has not been 
conclusively demonstrated in the tissue [2,13-151. 
We have been particularly interested in the biosyn- 
thesis of dipahnitoyl-sn-glycero-3-phosphocholine, 
which is the major component of pulmonary surfac- 
tant and is synthesized by the alveolar type II cells. 
In previous studies [ 12,16-l 81 , pulmonary adenomas 
induced by urethan were demonstrated to be a useful 
model for studies of lipid metabolism in alveolar 
type II cells. These benign adenomas consist almost 
exclusively of type II cells that contain lamellar bodies 
[ 19,201 and synthesize surfactant as normal type II 
cells [12,16] . However, surfactant biosynthesis is 
more active in adenoma type II cells than in whole 
lung [12,18] where type II cells comprise only 10% 
of the cells [21] . We found that adenomas incubated 
in Krebs-Ringer phosphate buffer incorporated 
[2-3H, 1 ,3-14C]gly cerol into the glycerol moiety of 
phosphatidylcholine and other lipids [ 121. This 
finding implied glycerol kinase is present and led us 
to examine the type II cells for activity. In the studies 
reported here, we demonstrate the conversion of 
labeled glycerol to glycerophosphate by glycerol 
kinase in cell-free preparations from adenoma type II 
cells. 
2. Materials and methods 
[U-14C] Glycerol (13 1 mCi/mmol) and sn-[ 1 -14C] 
glycero3-phosphate (120 mCi/mmol) were obtained 
North-Holland fiblishing Company - Amsterdam 
from New England Nuclear Corp. Trizma (pH 7.4) 
and glycine were obtained from Sigma Chemical Co. 
ATP was obtained from P-L Biochemicals and glycerol 
kinase (Candida mycoderma) was purchased from 
Boehringer Mannheim. 
Adenomas were harvested from the lungs of female 
BALB/c mice that had been injected i.p. with urethan 
(ethyl carbamate, 1 mg/g body weight on 3 consecutive 
days) approximately 6 months earlier [ 161. The 
harvested adenomas were suspended in 0.25 M sucrose 
(1 g/5 ml) containing 0.1 mM dithiothreitol and 
homogenized at 0-4”C. Subcellular fractionations 
were done by centrifugation [22]. The preparations 
were stored at -20°C. Protein was determined by the 
procedure of Lowry et al. [23]. 
The assay conditions were similar to those 
employed earlier [24,25] . Standard incubations at 
pH 7.4 were carried out at 37°C in total vol. 0.3 ml 
and contained Tris-HCl (80 mM, pH 7.4), dithio- 
threitol(O.1 mM), glycine (80 mM), ATP (20 mM), 
MgClz (6.6 mM), NaF (80 mM), and [‘4C]glycerol 
(0.5 @i, 3.8 nmol). The enzyme preparations were 
added and allowed to preincubate for 5 min before 
[14C]glycerol was added to initiate the reaction. 
Under the conditions of the assay, a linear response 
was obtained with commercial glycerol kinase. 
The glycerophosphate synthesized was routinely 
assayed by plating 20 1.t1 of the incubation mixture 
directly on Silica Gel G thin-layer plates that were 
then developed in chloroform/methanol/ammonium 
hydroxide (65:35:8, v/v/v). In this solvent system, 
glycero3-phosphate remained at the origin while 
glycerol migrated with an RF of 0.4. The distribution 
of radioactivity was determined by liquid scintillation 
spectrometry [26,27] . The glycerophosphate synthe- 
sized was further identified by paper chromatography 
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in ethyl acetate/acetic a id/water (3:3 : 1, v/v/v) [ 281. 
The paper (5 X 35 cm) was cut into 1 cm strips and 
the distribution of radioactivity determined by 
liquid scintillation counting. Authentic sn-glycero- 
3-phosphate and glycerol migrated with RF -values 
of 0.34 and 0.8, respectively, in this system. 
3. Results and discussion 
The conversion of [U-i4C]glycerol to [‘4C]glycero- 
phosphate was linear with protein concentrations 
from 20-200 Erg protein/vial but at concentrations 
greater than 300 pg a deviation in linearity occurred. 
In fact, the total activity observed ecreased at 
concentrations of homogenate greater than 300 pg 
protein until only 23% as much [i4C]glycerophos- 
phate was synthesized using 6 mg protein/vial as 
with 200 pg/vial. 
The reaction was linear with time for up to 20 min 
under our assay conditions. The specific activity 
observed in the homogenate was 44 pmol glycero- 
phosphate synthesized/min/mg protein. The apparent 
Km for glycerol (at 20 mM ATP concentrations) in
the system was 1.3 PM. Subcellular fractionations 
revealed most of the glycerol kinase activity is in the 
soluble fraction (table 1). 
The reaction was ATPdependent (table 1) and the 
[‘4C]glycerophosphate synthesized was identified by 
paper and thin-layer chromatography asdescribed in 
Materials and methods. Only two labeled compounds 
were detected in the products from the incubations: 
glycerophosphate and glycerol. 
The radioassay used here is more sensitive than 
the conventional spectrophotometric assay for glycerol 
kinase [ 13,241 and was carried out at pH 7.4 with no 
hydrazine in the assay mixture. The spontaneous loss 
of activity upon storage was arrested by the addition 
of dithiothreitol; this action of dithiothreitol implies 
the enzyme may have a reactive sulfhydryl group as 
do other glycerol kinases [24] . 
The failure of earlier studies to demonstrate 
glycerol kinase activity in whole lungs may be attri- 
butable to the conditions and sensitivity of the assay 
systems used. On the other hand, the alveolar type II 
cells comprise only 10% of the cells in normal ung 
[21] but may contain the bulk of the glycerol kinase 
activity. The high levels of protein from other cell 
types may have made it difficult to detect its activity, 
for in the present study protein concentrations greater 
than 1 mg/ml decreased the amount of glycerophos- 
phate synthesized. 
Although adenomas incorporate labeled glycerol 
into lipids at a higher ate than does minced lung, the 
labeling profiles of dipalmitoyl phosphatidylcholine 
and other lipids by glycerol are the same with the 
two tissues [121. The demonstration of glycerol 
kinase in the type II cells explains the route by which 
Table 1 
Subcellular distribution and ATPdependence of glycerol kinase in 
adenoma alveolar type II cellsa 
Fraction ATP 
(20 mM) 
[ 14C] Glycerophosphate synthesized 
(pmol/min/mg protein) 
Total homogenate + 60 
Total homogenate - 0.36 
Mitochondria 
(15 000 X g pellet) + 1.0 
Microsomes 
(100 000 X g pellet) + 0.39 
Soluble fraction + 180 
a Incubations were carried out for 20 min as described in Materials and methods. 
The following amounts of protein were added per vial: Total homogenate, 
336 Mg; mitochondria, 96 Gg; microsomes, 44 ng; and soluble fraction 100 pg. 
The values presented are averages obtained from duplicate incubations. 
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glycerol was incorporated into surfactant in the 
earlier whole-cell studies and indicates glycerol can 
be utilized directly by the lung for lipid synthesis 
without prior phosphorylation by other tissues. 
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